Public comment on draft basic policy for the 20th revision of the Japanese Pharmacopoeia
第二十改正日本薬局方作成基本方針(案)に関する御意見の募集について
Published: 2026-08-08 · Source: e-Gov Public Comment · Stage: Public Comment Closed · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · Comment deadline: 2026-09-07 00:00 JST · First detected by this dashboard: 2026-08-09
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
A draft basic policy for preparing the 20th revision of the Japanese Pharmacopoeia was announced for public comment on 2026/08/08. The listed comment deadline is 2026/09/07 00:00, and the responsible office is the Pharmaceutical Evaluation Division, Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare.
Business Impact
Pharmaceutical manufacturers may have an interest in the proposed direction for revising the Japanese Pharmacopoeia, but the listing does not describe specific proposed changes or requirements.
Recommended Action
Review of the official Japanese consultation materials could clarify the proposed revision policy, its scope and the comment submission requirements and deadline.